Loading...
Not a good buy right now. TILE’s medium-term technical setup is bullish (stacked moving averages and RSI ~62), but the near-term edge looks unfavorable given (1) the pattern-based model projecting a high-probability pullback (90% chance of ~-4% to -5% over the next day/week/month) and (2) sharply rising insider selling (+630% last month). With no Intellectia buy signal today and earnings still ahead (2026-02-24 pre-market), the risk/reward for an impatient entry at ~31.46 is unattractive; prefer to stay on hold rather than chase at current levels.
Trend is currently bullish: SMA_5 > SMA_20 > SMA_200 confirms an uptrend. RSI_6 at 61.99 is neutral-to-slightly-overbought (not a strong momentum buy signal). MACD histogram is positive (0.0177) but contracting, implying upside momentum is fading short-term. Key levels: pivot ~31.21; support S1 ~30.47 (then S2 ~30.02); resistance R1 ~31.94 and R2 ~32.40. Price (31.46) is just above pivot, meaning a breakdown below ~31.21 raises odds of a quick test of ~30.47.
Intellectia Proprietary Trading Signals
Additional near-term quant/pattern read: similar-pattern projection indicates elevated downside risk (90% probability of -4.39% next day, -4.12% next week, -5.34% next month), which conflicts with the longer-term uptrend and argues against buying immediately.

Analyst support: Barrington reiterated Outperform and raised price target to $36 (from $32), citing backlog strength and expectations for continued growth and expanding margins.
Fundamentals: strong Q3 (2025/Q
earnings quality—revenue +5.88% YoY with outsized profit/EPS growth, indicating operating leverage.
Upcoming event: QDEC 2025 earnings on 2026-02-24 (pre-market) can act as a catalyst if guidance/backlog converts to revenue as expected.
Insider activity: insiders are selling aggressively; selling amount up ~630% over the last month (bearish signal for near-term confidence).
Near-term downside skew from pattern-based projection (high probability of a pullback over day/week/month horizons).
Elevated implied volatility implies the market is pricing higher risk/uncertainty into the next month (often seen ahead of catalysts or during unstable price action).
No supportive near-term news flow in the past week to counterbalance the insider-selling headline and quant downside read.
Latest reported quarter: 2025/Q3. Revenue rose to $364.526M (+5.88% YoY). Profitability accelerated meaningfully: net income $46.146M (+62.92% YoY) and EPS $0.78 (+62.50% YoY). Gross margin improved to 39.4% (+6.29% YoY). Overall: solid growth with expanding margins (positive operating leverage trend).
Recent trend: supportive and improving. On 2026-01-23, Barrington raised the price target to $36 (from $32) and maintained an Outperform rating, highlighting backlog up 17% YTD exiting Q3 and expecting continued growth and margin expansion. Wall Street pros: backlog-driven growth visibility, margin expansion, and ‘attractive valuation’ per the analyst. Wall Street cons (implied by current data): near-term uncertainty into the 2026-02-24 earnings event, elevated IV, and the market-facing negative signal from heavy insider selling.